Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KANALRAD: Induction mDCF in Locally Advanced Anal Cancer
NCT06207981Phase 3Recruiting
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Feb 2024
- Primary completion
- Feb 2029
- Modality
- Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in anal squamous cell carcinoma (SCCA), sponsored by Fédération Francophone de Cancérologie Digestive. Started Feb 2024; status: recruiting.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracil
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT06207981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06207981.